Prolytix’s Post

View organization page for Prolytix, graphic

2,606 followers

GMP stability and release testing for large-molecule biopharmaceuticals and proteinaceous In Vitro Diagnostic (IVD) reagents are challenging due to the complex nature of these products and the stringent requirements for their use in clinical settings. Due to this complexity, it is essential to partner with a bioanalytical CRO like Prolytix that offers sophisticated analytical techniques to fully characterize each molecule and ensure batch-to-batch consistency.   A new blog post delves into GMP stability and release testing challenges for large-molecule drugs and the services Prolytix offers to address these challenges. Read more: https://lnkd.in/ekMCisnN John Moriarity #GMPStabilityTesting #GMPReleaseTesting #BionalyticalCRO

Addressing GMP Stability Testing and GMP Release Testing Challenges for Advanced Biotherapeutics

Addressing GMP Stability Testing and GMP Release Testing Challenges for Advanced Biotherapeutics

Prolytix on LinkedIn

To view or add a comment, sign in

Explore topics